A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

At every level of leadership, Premier’s experts are driving healthcare forward.

Leadership
Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.  

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.  

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Data, inquiry and intervention services.

Our most recent insights, articles and more, all in one place.  

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

It’s Time to Rethink Cancer Care

premier-celebrates-breakthroughs.jpg#asset:1291

Earlier this year, I had the privilege of convening stakeholders from different parts of the oncology world to discuss precision medicine. The goal was to better understand issues, challenges and opportunities in the oncology market from the perspective of its key stakeholders. A mix of 45 clinicians and executives from various types of organizations took part in this session, including payers, academic medical centers, oncology clinics, National Cancer Institute Designated Cancer Centers, and pharmaceutical, biotech, medical device, diagnostic and data companies.

For years, the industry has been clamoring for solutions around improving patient outcomes through evidence-based care and precision medicine. The only path forward to addressing this need is through an open dialogue with the various players involved. Coming out of our session, we boiled down our key takeaways into nine buckets.

Clinical Research

Clinical trial design needs to be informed by stakeholders early in the process. Research needs to extend beyond genetic mutations and take a more holistic view of the patient’s full profile and environmental factors.

Data

Stakeholders articulated an inability to extract data from its primary source to share with others who would benefit from it. There is a thirst for information on the successes and failures of on-label and off-label (e.g., using a therapy for a condition other than what it has been officially indicated for) use of targeted therapies.

We all realized that an aggregator of data that can be integrated into the clinical practice for oncologists is necessary for fostering better care. With an increasing amount of data available faster than ever before, providers are challenged with constantly staying up to date with the latest information. The electronic health records (EHRs) that have become ubiquitous were described as part of the problem – not the solution – with respect to data management and use.

Standardization of Treatment

The lack of data standardization is a universal source of consternation for all stakeholders. There is a clear need to standardize clinical data, measures and practices so that oncologists are better informed on how to treat their patients.

Guidelines and Pathways

The standards of care that are already in place need to be developed into more formal guidelines and pathways that are relevant, practical and derived from real-world evidence. There need to be reliable and consistent strategies to drive and implement this evidence-based care.

Molecular Testing

There is too much variation in what are considered best practices when it comes to the “who,” “what,” “when,” “where” and “why” of testing. Everyone is searching for clarity. At this point, practices vary widely when it comes to timing and, interestingly, between primary cancer centers and their affiliated community oncology practices.

Organizational Constraints for Providers

The provider stakeholders pointed out that they have internal organizational constraints associated with resources — including staffing shortages and high turnover in pathology, pharmacy and nursing — along with the fiscal challenges of high medication and procedure costs and falling reimbursement.

Need for Access to Resources

There is a need to revisit the resources available to all parties, such as pharmaceutical manufacturers’ reimbursement support programs, care coordination programs and others. These could be leveraged as a means of addressing staffing and cost constraints and potentially eliminate some communication barriers.

Focus on System-Level Integration

All stakeholders are looking for solutions that will enable them to integrate on an enterprise level. Health systems need to track and manage patients across the continuum of care – from inpatient (e.g., hospital) to outpatient (e.g., doctor’s office) settings. This requires having the proper technology solutions in place to allow visibility across the entire patient journey.

Additionally, communication between providers is often lacking. Working together collaboratively will allow the organizations to provide high-quality, evidence-based care with greater coordination throughout the entire process. At the end of the day, the seamless integration of technology and communication best serves patients as they receive care from infusion clinics, doctor’s offices, hospitals or any other sites of care.

Education

Across all stakeholder groups – including patients – there is a need for education on precision medicine and testing to ensure that patients receive the right care (e.g., lab tests, therapies, etc.) at the appropriate point in their treatment plan.

This session we hosted is proof that interdisciplinary collaborations can work when it comes to navigating complex issues. It supports the notion that advancements in this space, including data aggregation, clinical decision support tools, order sets, clinical program development and industry-derived oncology guidelines and pathways are critical to realizing the full potential of precision medicine in oncology.

When it comes to cancer care, innovation can’t happen in a vacuum. There are too many moving parts and considerations to work in silos.

Login Register Change Registration